Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity
2014-01-01 Mazzoccoli, G; Vinciguerra, M; Oben, J; Tarquini, R; De Cosmo, S
A ticking clock links metabolic pathways and organ systems function in health and disease
2013-01-01 Vinciguerra, M; Tevy, Mf; Mazzoccoli, G
The circadian clock and the hypoxic response pathway in kidney cancer
2014-01-01 Mazzoccoli, G; De Cata, A; Piepoli, A; Vinciguerra, M
Cerebrovascular, cognitive and cardiac benefits of SGLT2 inhibitors therapy in patients with atrial fibrillation and type 2 diabetes mellitus: Results from a global federated health network analysis.
2022-01-01 Proietti, ; R, ; Rivera-Caravaca, ; Jm, ; López-Gálvez, ; R, ; Harrison, ; Sl, ; Marin, ; F, ; Underhill, ; P, ; Shantsila, ; E, ; Mcdowell, ; G, ; Vinciguerra, M; Davies, ; R, ; Giebel, ; C, ; Lane, ; Da, ; Lip, ; Ghy,
Circadian clock circuitry in colorectal cancer
2014-01-01 Mazzoccoli, G; Vinciguerra, M; Papa, G; Piepoli, A
Protein kinases and phosphatases as drug targets to cure human malignancies
2008-01-01 Vinciguerra, M
Hormones, reproduction and disease in the longest-lived rodent: the naked mole rat.
2011-01-01 Vinciguerra, M
Hormone and cytokine circadian alteration in non-small cell lung cancer patients
2012-01-01 Mazzoccoli, G; Sothern, Rb; Francavilla, M; Giuliani, F; Carughi, S; Muscarella, La; Fazio, Vm; Parrella, P; Vinciguerra, M; Tarquini, R
Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib
2015-01-01 Mazzoccoli, G; Miele, L; Oben, J; Grieco, A; Vinciguerra, M
PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signaling
2006-01-01 Vinciguerra, M; Foti, M
A Timeless Link Between Circadian Patterns and Disease
2016-01-01 Mazzoccoli, G; Laukkanen, Mo; Vinciguerra, M; Colangelo, T; Colantuoni, V
Hormonal Control of Na,K-ATPase in mammalian collecting duct principal cells.
2005-01-01 Vinciguerra, M; Vandewalle, A; Feraille, E
Interventions to Slow Aging in Humans: Are We Ready?
2015-01-01 Longo, Vd; Antebi, A; Bartke, A; Barzilai, N; Brown-Borg, Hm; Caruso, C; Curiel, Tj; De Cabo, R; Franceschi, C; Gems, D; Ingram, Dk; Johnson, Te; Kennedy, Bk; Kenyon, C; Klein, S; Kopchick, Jj; Lepperdinger, G; Madeo, F; Mirisola, Mg; Mitchell, Jr; Passarino, G; Rudolph, Kl; Sedivy, Jm; Shadel, Gs; Sinclair, Da; Spindler, Sr; Suh, Y; Vijg, J; Vinciguerra, M; Fontana, L.
Targeting chromatin remodelers to treat hepatocellular carcinoma.
2012-01-01 Vinciguerra, M
Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD)
2013-01-01 Podrini, C; Borghesan, M; Greco, A; Pazienza, V; Mazzoccoli, G; Vinciguerra, M
SIRT1 signaling as potential modulator of skeletal muscle diseases
2012-01-01 Tonkin, J; Villarroya, F; Puri, Pl; Vinciguerra, M
Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy.
2010-01-01 Vinciguerra, M; Hede, M; Rosenthal, N
Molecular bases of circadian rhythmicity in renal physiology and pathology
2013-01-01 Bonny, O; Vinciguerra, M; Gumz, Ml; Mazzoccoli, G
The biological clock and the molecular basis of lysosomal storage diseases
2015-01-01 Mazzoccoli, G; Mazza, T; Vinciguerra, M; Castellana, S; Scarpa, M
Histone variants and lipid metabolism
2014-01-01 Borghesan, M; Mazzoccoli, G; Sheedfar, F; Oben, J; Pazienza, V; Vinciguerra, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity | 1-gen-2014 | Mazzoccoli, G; Vinciguerra, M; Oben, J; Tarquini, R; De Cosmo, S | |
| A ticking clock links metabolic pathways and organ systems function in health and disease | 1-gen-2013 | Vinciguerra, M; Tevy, Mf; Mazzoccoli, G | |
| The circadian clock and the hypoxic response pathway in kidney cancer | 1-gen-2014 | Mazzoccoli, G; De Cata, A; Piepoli, A; Vinciguerra, M | |
| Cerebrovascular, cognitive and cardiac benefits of SGLT2 inhibitors therapy in patients with atrial fibrillation and type 2 diabetes mellitus: Results from a global federated health network analysis. | 1-gen-2022 | Proietti, ; R, ; Rivera-Caravaca, ; Jm, ; López-Gálvez, ; R, ; Harrison, ; Sl, ; Marin, ; F, ; Underhill, ; P, ; Shantsila, ; E, ; Mcdowell, ; G, ; Vinciguerra, M; Davies, ; R, ; Giebel, ; C, ; Lane, ; Da, ; Lip, ; Ghy, | |
| Circadian clock circuitry in colorectal cancer | 1-gen-2014 | Mazzoccoli, G; Vinciguerra, M; Papa, G; Piepoli, A | |
| Protein kinases and phosphatases as drug targets to cure human malignancies | 1-gen-2008 | Vinciguerra, M | |
| Hormones, reproduction and disease in the longest-lived rodent: the naked mole rat. | 1-gen-2011 | Vinciguerra, M | |
| Hormone and cytokine circadian alteration in non-small cell lung cancer patients | 1-gen-2012 | Mazzoccoli, G; Sothern, Rb; Francavilla, M; Giuliani, F; Carughi, S; Muscarella, La; Fazio, Vm; Parrella, P; Vinciguerra, M; Tarquini, R | |
| Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib | 1-gen-2015 | Mazzoccoli, G; Miele, L; Oben, J; Grieco, A; Vinciguerra, M | |
| PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signaling | 1-gen-2006 | Vinciguerra, M; Foti, M | |
| A Timeless Link Between Circadian Patterns and Disease | 1-gen-2016 | Mazzoccoli, G; Laukkanen, Mo; Vinciguerra, M; Colangelo, T; Colantuoni, V | |
| Hormonal Control of Na,K-ATPase in mammalian collecting duct principal cells. | 1-gen-2005 | Vinciguerra, M; Vandewalle, A; Feraille, E | |
| Interventions to Slow Aging in Humans: Are We Ready? | 1-gen-2015 | Longo, Vd; Antebi, A; Bartke, A; Barzilai, N; Brown-Borg, Hm; Caruso, C; Curiel, Tj; De Cabo, R; Franceschi, C; Gems, D; Ingram, Dk; Johnson, Te; Kennedy, Bk; Kenyon, C; Klein, S; Kopchick, Jj; Lepperdinger, G; Madeo, F; Mirisola, Mg; Mitchell, Jr; Passarino, G; Rudolph, Kl; Sedivy, Jm; Shadel, Gs; Sinclair, Da; Spindler, Sr; Suh, Y; Vijg, J; Vinciguerra, M; Fontana, L. | |
| Targeting chromatin remodelers to treat hepatocellular carcinoma. | 1-gen-2012 | Vinciguerra, M | |
| Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD) | 1-gen-2013 | Podrini, C; Borghesan, M; Greco, A; Pazienza, V; Mazzoccoli, G; Vinciguerra, M | |
| SIRT1 signaling as potential modulator of skeletal muscle diseases | 1-gen-2012 | Tonkin, J; Villarroya, F; Puri, Pl; Vinciguerra, M | |
| Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy. | 1-gen-2010 | Vinciguerra, M; Hede, M; Rosenthal, N | |
| Molecular bases of circadian rhythmicity in renal physiology and pathology | 1-gen-2013 | Bonny, O; Vinciguerra, M; Gumz, Ml; Mazzoccoli, G | |
| The biological clock and the molecular basis of lysosomal storage diseases | 1-gen-2015 | Mazzoccoli, G; Mazza, T; Vinciguerra, M; Castellana, S; Scarpa, M | |
| Histone variants and lipid metabolism | 1-gen-2014 | Borghesan, M; Mazzoccoli, G; Sheedfar, F; Oben, J; Pazienza, V; Vinciguerra, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista131
Data di pubblicazione
- 2020 - 202424
- 2010 - 201953
- 2000 - 200953
- 1999 - 19991
Rivista
- NATURE REVIEWS CANCER14
- NATURE REVIEWS GENETICS14
- CLINICAL AND EXPERIMENTAL MEDICINE4
- EUROPEAN UROLOGY4
- IL GIUSTO PROCESSO CIVILE4
- AGING CELL3
- CURRENT PHARMACEUTICAL DESIGN3
- GIORNALE DI STORIA COSTITUZIONALE3
- HEPATOLOGY3
- IL PROCESSO3
Keyword
- angiogenesis2
- EMT2
- Aged1
- Angiogenesis1
- Anti-angiogenesis1
- anti-angiogenesis1
- apoptosis1
- Asbestos1
- Assemblea costiuente1
- BAP11
Lingua
- eng55
- ita21
Accesso al fulltext
- no fulltext131